Unmet Needs Surrounding mCRC Treatment
Key opportunities to improve the mCRC treatment landscape are illustrated by the expert panelists.
Source: onclive.com
📰 Evolving Treatment News
Evolving Treatment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evolving Treatment. Real-time updates on events, politics, business and more.
Anticipating Key Studies and Pipeline Treatments in mCRC Landscape
The experts provide their final thoughts surrounding the impact of prospective trials and therapy regimens for treating patients with refractory mCRC.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer Key Studies Pipeline Treatments
Source: onclive.com
Real-World Data Surrounding Sequencing Strategies for Refractory mCRC
Multiple abstracts from ESMO 2023, including a focus on tumor location, are highlighted.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer World Data Surrounding Sequencing Strategies
Source: onclive.com
Data Surrounding Treatment for MSI-high Patients from ASCO 2024
Dr Kim offers key perspective for MSI-high patients based on data presented at ASCO 2024.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer Surrounding Treatment Colorectal Cancer Mcrc Treatment
Source: onclive.com
Considerations for Platinum-based Therapy
Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer Asco Gi Adverse Event Profiles Hand Foot Skin Reactions
Source: onclive.com
Treatment Sequencing for Refractory mCRC and SUNLIGHT Study Analysis
Data presented at ESMO 2023 and ASCO GI 2024 highlight the impact of prior therapy, including VEGF inhibitors or fluoropyrimidine, on mCRC treatment approach.
Source: onclive.com
Compounding Impact of TAS-102 and Bevacizumab in mCRC Treatment
Marwan G Fakih, MD, drives a discussion highlighting a significant combination therapy in mCRC treatment.
Source: onclive.com
Fruquintinib MoA and Toxicity Profile Overview
Key safety considerations for the use of fruquintinib are explored.
Source: onclive.com
Evaluating 3L Treatment Landscape Evolution
Dr Parikh drives a conversation surrounding 3L treatment for patients diagnosed with metastatic colorectal cancer.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer Treatment Landscape Colorectal Cancer Colorectal Cancer Treatment
Source: onclive.com
Overview of Current mCRC Treatment Landscape
Medical experts open a discussion providing an update on the current impact of metastatic colorectal cancer and common treatment strategies.
Expert Perspectives Evolving Treatment Refractory Metastatic Colorectal Cancer Colorectal Cancer Metastatic Colorectal Cancer Mcrc Treatment Landscape
Source: onclive.com